Preparation and Characterization of Chitosan Microspheres Containing Doxifluridine
Authors:
- Yoshiharu MachidaYMYoshiharu Machida
- Hiraku OnishiHOHiraku Onishi
- Tsuneji NagaiTNTsuneji Nagai
- 1 January 2003
- journal article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 29 (4) , 417-427
Abstract
Chitosan microspheres containing 5-fluorouracil (5-FU), tegafur (FT), and doxifluridine (DFUR) were prepared by the dry-in-oil method using silicone oil with no surfactant as a dispersion medium. For DFUR-containing chitosan microspheres (DFUR-M), reacetylation with acetic anhydride or coating using chitosan and glutaraldehyde was performed. DFUR-M, reacetylated DFUR-M, and chitosan-coated DFUR-M were investigated on in vitro drug release, and the former two microspheres were examined for in vivo degradation after subcutaneous (s.c.) implantation in mice, and in vivo plasma concentration-time profiles after s.c. implantation in rats. The present method gave fairly large microspheres purely composed of chitosan and drug because of no use of surfactant, which showed the mean particle diameters of 300-900 microm and the drug contents of 4-22% (w/w). Encapsulation efficiency of DFUR was higher than that of 5-FU and FT. DFUR-M and reacetylated DFUR-M exhibited spherical shape except chitosan-coated DFUR-M. DFUR-M showed high initial rapid release, which was suppressed to some extent by reacetylation or chitosan coating. DFUR-M and reacetylated DFUR-M subcutaneously implanted were gradually degraded, and approximately half or a little more of the microspheres disappeared from the implanted site at 3 weeks postimplantation. DFUR-M and reacetylated DFUR-M implanted subcutaneously gave similar plasma concentration-time profiles of DFUR, which did not indicate prolonged release in vivo. DFUR-containing chitosan microspheres with fairly large size and good drug content could be obtained by the present preparation but remained to be improved for drug release properties.Keywords
This publication has 14 references indexed in Scilit:
- Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agentJournal of Microencapsulation, 2002
- In Vitro and in Vivo Evaluation of Sustained Release Chitosan-Coated Ketoprofen MicroparticlesYAKUGAKU ZASSHI, 2001
- Bioadhesive Characteristics of Chitosan Microspheres to the Mucosa of Rat Small IntestineDrug Development and Industrial Pharmacy, 2001
- Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres Coated with Chitosan to Improve Oral Delivery of ElcatoninPharmaceutical Development and Technology, 2000
- Chitosan for enhanced intestinal permeability: Prospects for derivatives soluble in neutral and basic environmentsEuropean Journal of Pharmaceutical Sciences, 1999
- Different Molecular Weight Chitosan Microspheres: Influence on Drug Loading and Drug ReleaseDrug Development and Industrial Pharmacy, 1998
- Pharmaceutical Application of Biomedical Polymers. Part XXXV. Chitosan and Sodium Alginate Based Bioadhesive Tablets for Intraoral Drug Delivery.Biological and Pharmaceutical Bulletin, 1994
- In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers.Chemical and Pharmaceutical Bulletin, 1988
- Lysozyme degradation of partially deacetylated chitin, its films and hydrogelsBiomaterials, 1982
- The Action of Lysozyme on Partially Deacetylated ChitinEuropean Journal of Biochemistry, 1978